AngioInsight, Inc. originated from the University of Michigan Medical School. The company is a seed-stage digital health artificial intelligence (AI) start-up located in Ann Arbor, Michigan. The company’s mission is to bring the benefits of AI to angiography and augment patient-specific treatment decisions to improve the clinical management of coronary artery disease (CAD) – one of the leading causes of death worldwide. We develop AI software to process angiographic images of patients with coronary artery disease, to help cardiologist make diagnostics decisions. The software relies on image processing, machine learning, and computational fluid dynamics analysis.